why choose us

First received: September 18, 2022

Clinical Trial: Susceptibility-Guided Sequential Therapy for Helicobacter Pylori Infection

Study Status: Completed

Recruit Status: RECRUITING

Condition: Helicobacter Pylori Infection

Study Type: INTERVENTIONAL


Official Title: Susceptibility-Guided Sequential Therapy Versus Empirical Therapy for Helicobacter Pylori Infection: a Randomised Controlled Trial

Brief Summary: The main objective of this trial is to assess whether a sequential therapy strategy based on molecular antibiotic susceptibility testing (including clarithromycin and fluoroquinolone) for H. pylori infection will improve the eradication rate compared to an empirical therapy.

Read more